Company page

Vir Biotechnology, Inc.

Vir Biotechnology, Inc. is a public company traded under the ticker VIR in the American market. The company has a market capitalization of approximately $1.45 billion. Vir Biotechnology focuses on developing therapies for infectious diseases, leveraging its expertise in immunology and biotechnology.